Immune System News and Research

RSS

Single-dose H1N1 vaccine wins approval in China

The Chinese biopharmaceutical company Sinovac Biotech Ltd. on Monday announced its H1N1 (swine) flu vaccine won the approval of a panel of experts from China's State Food and Drug Administration, the Associated Press/Forbes reports. The company expects to obtain a production license later this week. According to the company, clinical trials of the H1N1 vaccine showed a single shot produced an immune response capable of protecting against H1N1 (8/31).

2 Sep 2009

Polymyositis and dermatomyositis affected patients more prone to cardiovascular diseases

Patients suffering from two serious autoimmune disorders which cause muscular inflammation are at increased risk of developing cardiovascular disease, says a group of Montreal researchers. Dr. Christian A. Pineau and his team at the Research Institute of the McGill University Health Centre (RI-MUHC) have linked muscular inflammation to increased cardiovascular risk for the first time.

2 Sep 2009

Dr. Raman Bedi to exclusively represent Oragenics' oral care products

Florida-based biopharmaceutical leader Oragenics, Inc. has appointed renowned international oral care authority Dr. Raman Bedi to serve as exclusive representative for the company’s award-winning line of oral care products to the Middle East.

1 Sep 2009

Cimzia approved for treating adult patients with rheumatoid arthritis

UCB Canada Inc. announced today that Health Canada has approved Cimzia, the only PEGylated anti-TNF (Tumor Necrosis Factor), for the treatment of adult patients with moderately to severely active rheumatoid arthritis (RA).

1 Sep 2009

Phase II result reveals effectiveness of GS-101 eye drops at inhibiting corneal neovascularisation

Gene Signal, a company focused on developing innovative drugs to manage angiogenesis based conditions, today announced the publication of interim results from a phase II study suggesting that the antisense oligonucleotide GS-101 (eye drops) is safe and effective at inhibiting and regressing corneal neovascularisation (abnormal new blood vessel growth).

1 Sep 2009

VAERS calls for reporting of GBS cases following 2009 H1N1 flu vaccination

The Centers for Disease Control and Prevention (CDC) and the American Academy of Neurology (AAN) are requesting neurologists to report any possible new cases of Guillain-Barr- syndrome (GBS) following 2009 H1N1 flu vaccination using the CDC and U. S. Food and Drug Administration Vaccine Adverse Event Reporting System (VAERS).

1 Sep 2009

New technique developed for the treatment of cancer

A new paradigm in the way we look at cancer with important implications on how we treat it is about to be published in the British Journal of Cancer by Portuguese, Belgian and American researchers.

1 Sep 2009

Psychological therapy for breast cancer patients reduces blood inflammation levels

A psychological intervention for newly diagnosed breast cancer patients with symptoms of depression not only relieves patients' depression but also lowers indicators of inflammation in the blood.

1 Sep 2009

Mitoxantrone is highly efficient in suppressing multiple sclerosis

According to data supplied by the German Multiple Sclerosis Society's national MS register (DMSG - Deutsche Multiple Sklerose Gesellschaft), up to 10% of German MS patients have been treated with mitoxantrone in the past few years.

1 Sep 2009

Stanford University starts recruiting participants for swine flu vaccine clinical trial

The Stanford University School of Medicine is recruiting participants for a clinical trial to determine the safety of an experimental vaccine against the new H1N1 strain of influenza when the vaccine is combined with an immune-stimulating substance called an adjuvant. The trial will also examine whether use of the adjuvant improves the immune response to the vaccine.

31 Aug 2009

Cancer researcher to serve as Peregrine Pharmaceuticals' clinical advisor for bavituximab cancer program

Peregrine Pharmaceuticals, Inc., today announced that noted cancer researcher Bruce Chabner, M.D., will serve as a clinical advisor to the company on the design of clinical trials for the bavituximab cancer program.

31 Aug 2009

IDRI signs agreement to use NanoPass' MicronJet microneedle technology for intradermal vaccines

The Infectious Disease Research Institute (IDRI) and NanoPass Technologies Ltd. (NanoPass) today announced they have entered into an agreement whereby IDRI licenses NanoPass' proprietary MicronJet microneedle technology for the intradermal delivery of products against a number of diseases including tuberculosis, HIV, malaria, leishmaniasis and leprosy, among others. The financial details of the agreement are confidential.

31 Aug 2009

FDA approves the usage of Valcyte for preventing CMV disease in pediatric patients

Roche announced today that the U.S. Food and Drug Administration (FDA) has approved Valcyte(R) (valganciclovir hydrochloride) for the prevention of cytomegalovirus (CMV) disease in pediatric kidney and heart transplant patients (4 months to 16 years of age) at high risk of developing CMV disease.

31 Aug 2009

Cancer Immunotherapy Index of ten cancer immunotherapy stocks increases by 23%

The Cancer Immunotherapy Index of ten leading cancer immunotherapy stocks increased 23% since its inception July 10, 2009. The CI Index was developed by Mentor Capital as a peer group index against which investors could bench mark stock performance in the rapidly growing immunotherapy sector.

29 Aug 2009

University of California's entomology professors selected as fellows of ESA

Brian A. Federici and Alexander S. Raikhel, distinguished professors of entomology at the University of California, Riverside, have been selected as fellows of the Entomological Society of America (ESA).

29 Aug 2009

Members of the Blue Cross Blue Shield of Arizona to receive coverage for H1N1 vaccine

Blue Cross Blue Shield of Arizona (BCBSAZ) announced today that it will cover the H1N1 vaccine for all BCBSAZ members in addition to its regular coverage of a seasonal flu shot.

29 Aug 2009

TRAF6 protein can activate a cell signalling molecule associated with cancer

The mainstay immune system protein TRAF6 plays an unexpected, key role activating a cell signaling molecule that in mutant form is associated with cancer growth, researchers at The University of Texas M. D. Anderson Cancer Center report in the Aug. 28 edition of Science.

28 Aug 2009

Kenya launches malaria campaign; PBS' newshour airs segment on drug-resistance in Cambodia

Kenya on Thursday launched a national malaria campaign to encourage Kenyans to sleep under insecticide-treated nets (ITNs) every night to prevent infection, the Daily Nation reports.

28 Aug 2009

Infectious Disease Research Institute commences clinical trial of its leishmaniasis vaccine in Sudan

IDRI (Infectious Disease Research Institute) announced today the start of a clinical trial in Sudan to test its leishmaniasis vaccine candidate for the treatment of post kala-azar dermal leishmaniasis (PKDL), a complication of visceral leishmaniasis (VL) which is observed in 50% of patients treated for VL in the country, predominantly affecting children.

28 Aug 2009

AVI BioPharma's peptide-conjugated PMO chemistry to be discussed at two upcoming scientific meetings

AVI BioPharma, Inc., a developer of RNA-based drugs, today announced that Hong Moulton, Ph.D., Director of Discovery Research, will give oral presentations highlighting improved analogues of AVI's phosphorodiamidate morpholino oligomer (PMO) chemistry at two upcoming scientific meetings.

28 Aug 2009

Immune System News and Research

Single-dose H1N1 vaccine wins approval in China

Polymyositis and dermatomyositis affected patients more prone to cardiovascular diseases

Dr. Raman Bedi to exclusively represent Oragenics' oral care products

Cimzia approved for treating adult patients with rheumatoid arthritis

Phase II result reveals effectiveness of GS-101 eye drops at inhibiting corneal neovascularisation

VAERS calls for reporting of GBS cases following 2009 H1N1 flu vaccination

New technique developed for the treatment of cancer

Psychological therapy for breast cancer patients reduces blood inflammation levels

Mitoxantrone is highly efficient in suppressing multiple sclerosis

Stanford University starts recruiting participants for swine flu vaccine clinical trial

Cancer researcher to serve as Peregrine Pharmaceuticals' clinical advisor for bavituximab cancer program

IDRI signs agreement to use NanoPass' MicronJet microneedle technology for intradermal vaccines

FDA approves the usage of Valcyte for preventing CMV disease in pediatric patients

Cancer Immunotherapy Index of ten cancer immunotherapy stocks increases by 23%

University of California's entomology professors selected as fellows of ESA

Members of the Blue Cross Blue Shield of Arizona to receive coverage for H1N1 vaccine

TRAF6 protein can activate a cell signalling molecule associated with cancer

Kenya launches malaria campaign; PBS' newshour airs segment on drug-resistance in Cambodia

Infectious Disease Research Institute commences clinical trial of its leishmaniasis vaccine in Sudan

AVI BioPharma's peptide-conjugated PMO chemistry to be discussed at two upcoming scientific meetings

Immunology eBook

Achieving and maintaining ISO 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News